View More Recent Stories

Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview
Jan 6, 2025 04:30PM Kura Oncology (KURA) Announces Senior Executive Promotions
Dec 9, 2024 07:05AM Kura Oncology (KURA) and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
Nov 22, 2024 01:33PM Kura Oncology (KURA) PT Lowered to $11 at Stifel
Nov 21, 2024 07:50AM TD Cowen Reiterates Buy Rating on Kura Oncology (KURA)
Nov 21, 2024 06:35AM Kura Oncology (KURA) PT Raised to $37 at H.C. Wainwright
Nov 21, 2024 05:38AM Kura Oncology (KURA) PT Lowered to $28 at Jefferies
Nov 20, 2024 05:00PM Kura Oncology (KURA) and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
Nov 18, 2024 07:32AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)
Nov 7, 2024 04:31PM Kura Oncology (KURA) Reports In-Line Q3 EPS
Nov 5, 2024 09:13AM Kura Oncology (KURA) to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting
Oct 25, 2024 08:05AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)
Oct 24, 2024 04:03AM UBS Starts Kura Oncology (KURA) at Buy
Oct 14, 2024 12:41AM Stifel Downgrades Kura Oncology (KURA) to Hold
Sep 17, 2024 07:30AM Kura Oncology (KURA) Appoints Michael Vasconcelles to its Board
Aug 8, 2024 04:45PM Kura Oncology (KURA) Tops Q2 EPS by 4c
Aug 8, 2024 07:30AM Kura Oncology (KURA) Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors
Jun 25, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)
Jun 24, 2024 07:32AM Kura Oncology (KURA) Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes
Jun 18, 2024 08:45AM Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions
Mar 22, 2024 08:00PM 4 Buy-rated Healthcare stocks with 30-45% upside
View More Recent Stories